Molecular Pharmaceutics at CRS 2023 Annual Meeting
Around 20 members of the Department of Molecular Pharmaceutics attended the Controlled Release Society's 2023 Annual Meeting & Expo in Las Vegas from July 25 - 28, 2023. Of the thirteen abstracts submitted by our department, five received special recognition. This is remarkable considering there were a total of nearly 800 abstracts that were presented at the meeting!
We had three speakers:
Morgan Marsh (Ph.D student, Owen Lab): "Complementation Dependent Enzyme Prodrug Therapy for Targeted HER2 Positive Cancer Treatment.": BioEngineering Focus Group Winner of Bioengineering Focus Group Trainee Award
Dr. Shawn Owen: New and Emerging Technologies for Drug Delivery
Dr. You Han Bae: Journal of Controlled Release Session
And eleven posters:
HER2 levels alone are not indicative of response to HER2- Targeting Therapy, Dr. Shawn Owen
Injectable Antibacterial Dressings for the Treatment of Chronic Rhinosinusitis (CRS) Bhuvanesh Yathavan WINNER OF BEST POSTER AWARD IN THE CATEGORY
Development of Next Generation Antibody-Polymer-Drug Conjugates Dr. Jane Yang
Artificial T Cell Activation Strategy Incorporating Receptor Crosslinking Michael Gambles
Drug Encapsulation for Optimal Dosing of Patients on Extracorporeal Membrane Oxygenation Systems Kamiya Watkins
Targeted Paclitaxel Conjugate for the Treatment of Alzheimer Disease Shannuo Li
Multivalent DR5 receptor clustering agonists for treatment of colon cancer Jiahui Li WINNER OF BEST POSTER AWARD IN THE CATEGORY
Micellar Encapsulation of Propofol Reduces its Adsorption to Extracorporeal Membrane Oxygenator (ECMO) Circuit Dr. Nitish Khurana WINNER OF BEST POSTER AWARD IN THE CATEGORY
Systemic Administration of Budesonide in Pegylated Liposomes for Improved Efficacy in Chronic Rhinosinusitis Bhuvanesh Yathavan
Nanomedicine Strategies for Heating ‘Cold’ Tumors with Concurrent PD-L1 Attenuation Dr. Jane Yang, Dr. Hassan A. Faruque WINNER OF BEST POSTER AWARD IN THE CATEGORY
Ultradeformable Cationic Liposomes (UCL)-mediated Transdermal Delivery of miR211-5p as a Potential Chemopreventive Therapy for Melanoma Tanya Chhibber
